Alotaibi G, Seraj H, AlMulihi Q, Alkhawajah A, Eshbeer S, Alghamdi A
Cureus. 2024; 16(6):e62292.
PMID: 39006605
PMC: 11246175.
DOI: 10.7759/cureus.62292.
Qu S, Zou Y, Yang L, Wu H
Front Med (Lausanne). 2024; 10:1280776.
PMID: 38259837
PMC: 10800625.
DOI: 10.3389/fmed.2023.1280776.
Huemer J, Khalid H, Wagner S, Nicholson L, Fu D, Sim D
Eye (Lond). 2020; 35(10):2812-2819.
PMID: 33257803
PMC: 8452616.
DOI: 10.1038/s41433-020-01317-9.
Zhang Y, Duan J, Chang T, Li X, Wang M, Zhang M
Medicine (Baltimore). 2020; 99(38):e22267.
PMID: 32957378
PMC: 7505385.
DOI: 10.1097/MD.0000000000022267.
Abdelkawi S, Hassan A, Fouad Ghoneim D, Saif A
J Lasers Med Sci. 2019; 10(1):50-55.
PMID: 31360369
PMC: 6499588.
DOI: 10.15171/jlms.2019.08.
Efficacy of panretinal laser in ischemic central retinal vein occlusion: A systematic review.
Li C, Wang R, Liu G, Ge Z, Jin D, Ma Y
Exp Ther Med. 2019; 17(1):901-910.
PMID: 30651879
PMC: 6307409.
DOI: 10.3892/etm.2018.7034.
End Stage Renal Disease as a Potential Risk Factor for Retinal Vein Occlusion.
Chen S, Yang T, Lin J, Lian I
Medicine (Baltimore). 2015; 94(47):e1960.
PMID: 26632690
PMC: 5058959.
DOI: 10.1097/MD.0000000000001960.
Neovascular Glaucoma.
Havens S, Gulati V
Dev Ophthalmol. 2015; 55:196-204.
PMID: 26501989
PMC: 5664957.
DOI: 10.1159/000431196.
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review.
Glanville J, Patterson J, McCool R, Ferreira A, Gairy K, Pearce I
BMC Ophthalmol. 2014; 14:7.
PMID: 24447389
PMC: 3904417.
DOI: 10.1186/1471-2415-14-7.
Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion.
Fortunato P, Pollazzi L, Baroni M, Evangelisti A, La Torre A
Graefes Arch Clin Exp Ophthalmol. 2009; 248(2):167-73.
PMID: 19756692
PMC: 2801847.
DOI: 10.1007/s00417-009-1187-2.
The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.
Klein R, Klein B, Moss S, Meuer S
Trans Am Ophthalmol Soc. 2001; 98:133-41; discussion 141-3.
PMID: 11190017
PMC: 1298220.
Arterial blood flow characteristics in central retinal vein occlusion and effects of panretinal photocoagulation treatment: an investigation by colour Doppler imaging.
Avunduk A, Dinc H, Kapicioglu Z, Ugurlu S, Dayanir V, Korkmaz E
Br J Ophthalmol. 1999; 83(1):50-3.
PMID: 10209435
PMC: 1722785.
DOI: 10.1136/bjo.83.1.50.
Central retinal vein occlusion: what's the story?.
Williamson T
Br J Ophthalmol. 1997; 81(8):698-704.
PMID: 9349161
PMC: 1722295.
DOI: 10.1136/bjo.81.8.698.
Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.
Elman M
Trans Am Ophthalmol Soc. 1996; 94:471-504.
PMID: 8981710
PMC: 1312109.
Aqueous flare and cells in eyes with retinal vein occlusion--correlation with retinal fluorescein angiographic findings.
Nguyen N, Kuchle M
Br J Ophthalmol. 1993; 77(5):280-3.
PMID: 8318463
PMC: 504505.
DOI: 10.1136/bjo.77.5.280.
Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study.
Wolf S, Arend O, Bertram B, Remky A, Schulte K, Wald K
Graefes Arch Clin Exp Ophthalmol. 1994; 232(1):33-9.
PMID: 8119599
DOI: 10.1007/BF00176435.
Correlation of electroretinographic and fluorescein angiographic findings in unilateral central retinal vein obstruction.
Matsui Y, KATSUMI O, MEHTA M, Hirose T
Graefes Arch Clin Exp Ophthalmol. 1994; 232(8):449-57.
PMID: 7926880
DOI: 10.1007/BF00195353.
Combined central retinal artery-central vein obstruction.
Brown G, Duker J, Lehman R, Eagle Jr R
Int Ophthalmol. 1993; 17(1):9-17.
PMID: 7686140
DOI: 10.1007/BF00918861.
Central Vein Occlusion Study: photographic protocol and early natural history.
CLARKSON J
Trans Am Ophthalmol Soc. 1994; 92:203-13; discussion 213-5.
PMID: 7533959
PMC: 1298507.
Rubeotic glaucoma.
Smith R
Br J Ophthalmol. 1981; 65(9):606-9.
PMID: 7295627
PMC: 1039605.
DOI: 10.1136/bjo.65.9.606.